Correction to: Genomic Subtyping in Bladder Cancer

Tuomas Jalanko^{1

2}, Joep J de Jong³, Ewan A Gibb⁴, Roland Seiler⁵, Peter C Black⁶

Affiliations

¹ Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada.
² Department of Urology, Helsinki University, Helsinki, Finland.
³ Department of Urology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
⁴ Decipher Biosciences, Vancouver, Canada.
⁵ Department of Urology, University of Bern, Bern, Switzerland.
⁶ Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada. pblack@mail.ubc.ca.

Published Erratum

Tuomas Jalanko et al. Curr Urol Rep. 2020.

. 2020 May 14;21(7):25.

doi: 10.1007/s11934-020-00977-0.

Tuomas Jalanko^{1

2}, Joep J de Jong³, Ewan A Gibb⁴, Roland Seiler⁵, Peter C Black⁶

¹ Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada.
² Department of Urology, Helsinki University, Helsinki, Finland.
³ Department of Urology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
⁴ Decipher Biosciences, Vancouver, Canada.
⁵ Department of Urology, University of Bern, Bern, Switzerland.
⁶ Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada. pblack@mail.ubc.ca.

Abstract

The original version of this article contained a mistake. The included Conflict of Interest statement was incorrect.

Genomic Subtyping in Bladder Cancer.
Jalanko T, de Jong JJ, Gibb EA, Seiler R, Black PC. Jalanko T, et al. Curr Urol Rep. 2020 Mar 13;21(2):9. doi: 10.1007/s11934-020-0960-y. Curr Urol Rep. 2020. PMID: 32166460 Review.